Loading clinical trials...
Loading clinical trials...
The study aimed to test whether group reminiscence intervention for inpatients with schizophrenia is feasible, acceptable and preliminary effective. The effect of the intervention was evaluated on cog...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
The Hashemite University
NCT07242586 · SCHIZOPHRENIA 1 (Disorder), Schizotypal Disorder, and more
NCT07371325 · SCHIZOPHRENIA 1 (Disorder), Metabolic Abnormalities, and more
NCT07454200 · SCHIZOPHRENIA 1 (Disorder), Hospitalized Adult Patients
NCT06817980 · SCHIZOPHRENIA 1 (Disorder), Borderline Personality Disorder, and more
NCT02038465 · Schizophrenia Cognition Autobiographical Memory Cognitive Remediation
The Hashemite University
Zarqa
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions